Bedrijf laden
Just reported
Q3 FY2027 results
From Kenvue's results release of 30 oktober 2026; its quarterly report has since been filed.
Revenue
Actual
US$ 3,89B
+3,2% y/y
-1,7% q/qGuided
—
No guide given
EPS, GAAP
Actual
US$ 0,22
+4,8% y/y
-8,3% q/qGuided
—
No guide given
Operating income, GAAP
Actual
US$ 706M
+12% y/y
+1,0% q/qGuided
—
No guide given
Set against the company's own guidance and the same quarter a year earlier, not analysts' estimates, which we do not hold. Adjusted figures are the company's own non-GAAP measures, as stated in the release.
The full earnings report →Keep exploring
The themes Kenvue is part of, the highest-graded companies in its industry, and the companies in its sector whose grade rose recently.
The theme it is part of
Highest-graded in Household and Personal Products
Graded A or B and worth $2B or more: A first, then the largest.
PGProcter & Gamble CoUS$ 393,6BA+
CLColgate-Palmolive CompanyUS$ 79,2BA
ELFe.l.f. Beauty, Inc.US$ 7BA
ELEstee Lauder Companies IncUS$ 40,5BB
IPARInterparfums, Inc.US$ 4,3BB+
Grade rose recently in Consumer Staples
Rose to A or B on a filing in the last 90 days, worth $2B or more: largest first.
BUDAnheuser-Busch InBev SA30 jul 2026BAGraded B, now A
MDLZMondelez International, Inc.29 okt 2026CAGraded C, now A
HSYHershey Co.29 okt 2026BAGraded B, now A
SYYSysco Corporation4 nov 2026BAGraded B, now A- ELFe.l.f. Beauty, Inc.4 nov 2026BAGraded B, now A
Hoe het geld verdient
- Self Care43%
- Essential Health31%
- Skin Health and Beauty27%
De omzetaandelen zijn schattingen voor quarter ended 2026-09-27, geen cijfers uit een ingediend rapport.
Concurreert met
- HLNHaleon plcB
- Omvang
- US$ 41,1B
- Marge
- 15,1%
- PGThe Procter & Gamble CompanyA
- Omvang
- US$ 393,6B
- Marge
- 18,2%
- RBGLYReckitt Benckiser Group plc
- LRLCYL'Oréal S.A.
- ULUnilever PLCD
- Omvang
- US$ 144,4B
- Marge
- 18,7%
- CLColgate-Palmolive CompanyA
- Omvang
- US$ 79,2B
- Marge
- 9,6%
Wat het verkoopt6
Tylenol
Nonprescription medicines for pain and fever.
Zyrtec
Medicines for allergy symptoms.
Nicorette
Products to help people stop smoking.
Nog 3 tonen
Neutrogena
Skin and hair care products, including face and body care.
Listerine
Mouthwash and other oral care products.
BAND-AID Brand
Adhesive bandages and other wound-care products.
Wie het koopt3
- Retailers and pharmacies buy branded products for resale in stores and through their online shops.
- Online retailers sell Kenvue products to consumers through e-commerce channels.
- Consumers buy the products through retail, pharmacy and online channels.
Waar het op steunt, en wat het kan breken
Waar het bedrijf van afhangt
- 1Kenvue relies on outside manufacturers for some products and on third-party operators for most of its distribution centers.
- 2It buys most raw and packaging materials from outside suppliers; some materials come from a single supplier or a limited number of suppliers, and commodity prices can change.
- 3Some legacy Johnson & Johnson names and branding, including Johnson’s, are used under licenses with varying durations.
Wat er mis kan gaan
- 1The pending combination with Kimberly-Clark depends on remaining regulatory approvals and other closing conditions; delay or failure to complete it could disrupt operations, customers, suppliers or employees.
- 2Product safety, ingredient or labeling concerns can lead to recalls, regulatory action, lawsuits and reputational harm; Kenvue also faces talc-related proceedings involving Johnson’s Baby Powder sold outside the United States and Canada.
- 3Competition from other brands and retailer-owned products, changing consumer preferences, and retailers’ ordering and inventory decisions can affect sales; Kenvue has also faced distribution losses in some product categories.
Over Kenvue Inc.
Its brands include Tylenol and Zyrtec medicines, Neutrogena skin and hair care, Listerine mouthwash, and BAND-AID wound-care products. It sells through retail and online channels around the world. Kenvue has a pending agreement to combine with Kimberly-Clark, subject to remaining conditions and regulatory approvals.
- Hoofdkantoor
- Summit, New Jersey, United States
- Opgericht in
- 2022
- Medewerkers
- approximately 22,000 (as of December 28, 2025, high)
- Genoteerd aan
- NYSE
- Einde boekjaar
- December
Gebouwd uit de eigen deponeringen van Kenvue Inc. bij de Amerikaanse toezichthouder Securities and Exchange Commission (SEC). De cijfers zijn zoals gerapporteerd, met de historie per aandeel herrekend naar de huidige aandelenbasis. Dit beschrijft een bedrijf — het is geen beleggingsadvies en geen aanbeveling om iets te kopen of te verkopen.
